DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Kymera Therapeutics News

Kymera Therapeutics Signs $750 Million Cancer Drug Deal With Gilead Including $85 Million Upfront Amid Sanofi IRAK4 Setback

Kymera Therapeutics Signs $750 Million Cancer Drug Deal With Gilead Including $85 Million Upfront Amid Sanofi IRAK4 Setback

13

1 month ago

Latest stories